FitLife Brands (FTLF) LD Micro 20th Annual Main Event Conference summary
Event summary combining transcript, slides, and related documents.
LD Micro 20th Annual Main Event Conference summary
21 Oct, 2026Business model and growth history
Owns 16 nutritional supplement and wellness brands; capital-light model owns brands and IP, outsources manufacturing, and sells through online, wholesale, retail, and GNC franchise channels.
Online sales represent about half of revenue; major retail and wholesale outlets include Walmart, CVS, Walgreens, Costco Canada, Sprouts, Fresh Thyme, and Whole Foods.
After revenue fell to $16.2 million and EBITDA turned negative, online sales growth helped restore revenue and positive EBITDA, repay debt, and build cash.
Acquisitions included Nutrology in 2021, MRC in 2023, MusclePharm in 2023, and Irwin Naturals; Irwin roughly doubled the business.
LTM revenue exceeded $100 million and LTM EBITDA exceeded $14 million, including almost a full year of Irwin Naturals.
Capital allocation and shareholder alignment
Cash flow from existing brands funds acquisitions; deals are paid for in cash, with debt used for acquisitions and then aggressively repaid.
No shares have been issued for acquisitions; 9.4 million shares were outstanding on a fully diluted basis, with total shares including options below 10 million.
CEO ownership was 60% fully diluted and 56.4% of currently outstanding shares; other insiders also hold shares.
The portfolio is a fragmented-market consolidation play; acquisitions are sought at 3x-6x cash flow, with synergy-adjusted cash flows targeted to rerate at 12x-14x EBITDA.
Four deals closed after reviewing 75+ NDAs over roughly five years; recent targets presented were often declining, and none of the roughly two dozen deals reviewed in the past year was growing.
Margin and operating improvements
Irwin Naturals lowered blended gross margin to the mid-30s to high-30s from low-40s before the acquisition; adjusted EBITDA margin had reached 20% previously.
Irwin historically discarded over $1 million, near $2 million, of product annually; formulas were transitioned to three-year shelf life, extending sellable time from 12 to 24 months.
Inventory benefits will build as old stock cycles through, with full monetization expected over the next one to two years.
Fulfillment and transportation changes reduced costs, with impact expected beginning in Q3 and more in Q4; SG&A savings and headcount adjustments were also implemented.
Latest events from FitLife Brands
- Q2 2026 revenue jumped 65% year-over-year, led by Irwin Naturals, but gross margin declined.FTLF
Q2 2026 - Shareholders will vote on five directors and auditor ratification at the August 2026 meeting.FTLF
Proxy filing - Director elections and auditor ratification headline a sustainability-focused annual meeting.FTLF
Proxy filing - Board recommends director and auditor approval; CEO holds majority of shares.FTLF
Proxy filing - Q1 2026 revenue up 59% to $25.3M, but net income down to $1.7M on margin and cost pressures.FTLF
Q1 2026 - Q4 revenue up 73% on Irwin acquisition, but margin and demand pressures persist.FTLF
Q4 2025 - Q3 revenue up 15% to $16M, net income $2.1M, margin 43.8%, online sales drove growth.FTLF
Q3 2024 - Profitable, online-focused supplement operator leverages M&A and innovation for sustained growth.FTLF
Planet MicroCap Showcase: VEGAS 2025 - Strong 2024 growth, margin gains, and robust online sales; Q1 2025 faces tough comps.FTLF
Q4 2024